The envelope protein, gp52, of the mouse mammary tumour virus (MMTV) 
INTRODUCTION
The mouse mammary tumour virus (MMTV) is an enveloped virus that binds to and fuses with the plasma membrane of its host cell (White, 1990 ). This process is accomplished by an envelope glycoprotein that both recognizes a specific cellular receptor and acts as a fusogen (Schochetman, Long & Massey, 1979) . Such viral protein-receptor inter¬ actions are often highly specific and account, in part, for the tissue tropism of the virus (Lentz, 1990 (Topper & Freeman, 1980) (Bolander & Blackstone, 1990 (Vonderhaar, Owens & Topper, 1973 Ritzi, Baldi & Spiegelman (1976) and the viral proteins were then isolated using the protocol of Marcus, Kopelman & Sarkar (1979) . The final preparation showed only one band on sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Although the band represented a protein having a molecular weight of 58 kDa, others have reported a molecular weight of only 52kDa; therefore, the standard nomenclature of gp52 will be used. The 125I-labelled gp52 was prepared by a modification (Bolander & Fellows, 1975) (Fig. 3) . These changes were not seen with the binding protein on liver cells (Fig. 3) (Lentz, 1990) . Secondly, its ubiqui¬ tous distribution is consistent with the fact that the initial infection at the time of suckling involves nearly all the tissues in the mouse (Nandi & McGrath, 1973) . Thirdly, other strains of MMTV also bound to this protein (Fig. 2) . Fourthly, Scatchard analysis revealed only one binding site (Fig. 1) (Muñoz & Bolander, 1989; Bolander & Blackstone, 1990) and mammary epithelial reinfection is occur¬ ring (Nagasawa, Nakajima, Morimoto et al. 1982 ). The expression of MMTV by the mammary gland is much greater than in any other tissue (Ross, Hsu, Choi et al. 1990 (Salmons & Gunzburg, 1987; Tsubura & Morii, 1987; Henrard & Ross, 1988) and oncogenes linked to the MMTV long terminal repeat (LTR) in transgenic mice (Choi, Henrard, Lee & Ross, 1987 (Ono, Kawakami & Ushikubo, 1987; Bradham & Bolander, 1989) or, at high concentrations, by acting through the androgen receptor (Glover & Darbre, 1989) . All of the aforementioned tissues are targets of one or more of these steroids (Martin, 1985) 
